Description
The c.1493G>T (p.R498L) alteration is located in exon 6 (coding exon 6) of the SMPD1 gene. This alteration results from a G to T substitution at nucleotide position 1493, causing the arginine (R) at amino acid position 498 to be replaced by a leucine (L). Based on data from the Genome Aggregation Database (gnomAD) database, the SMPD1 c.1493G>T alteration was observed in 0.01% (36/282454) of total alleles studied, with a frequency of 0.28% (29/10346) in the Ashkenazi Jewish subpopulation. This mutation (also referred to as p.R496L) has been reported in the homozygous and compound heterozygous states in patients with SMPD1-related Niemann-Pick disease and is a common mutation in the Ashkenazi Jewish population (Levran, 1991; Ricci, 2004; Cox, 2018). Other alterations at this amino acid position have also been reported in affected patients (Simonaro, 2002; Ricci, 2004). Functional studies demonstrated reduced enzymatic activity in patient fibroblasts and transgenic mice with this mutation (Jones, 2008). The p.R498L alteration is predicted to be deleterious by in silico analysis. Based on the available evidence, this alteration is classified as pathogenic.
# | Sample | Method | Observation |
---|
Origin | Affected | Number tested | Tissue | Purpose | Method | Individuals | Allele frequency | Families | Co-occurrences |
---|
1 | germline | unknown | not provided | not provided | not provided | | not provided | not provided | not provided | not provided |